A rap video used to motivate Insys Therapeutics’ salesforce into promoting higher doses of its opioid drug Subsys is the latest piece of evidence in the increasingly-bizarre trial of chairman Jo
Sanofi’s strategy of betting on new drugs and biotech acquisitions seems to be paying off, as the company has forecast growth for 2019 thanks to higher than expected quarterly earnings and
OPEN Health has restructured its eight businesses into four specialist practices, in a move that will see it retire names such as LEC, Reynolds-MacKenzie and Harvey Walsh.
Havas Lynx were the big winners of the 33rd annual PM Society Awards on Friday 1 February, scooping nine Gold awards across work for three different clients.
The Healthware Group is set to further increase its digital health offering after agreeing a €10 million deal with Italy’s first late-stage venture capital fund.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.